\
&
Contact us
\
&
Contact us
This was 11 months ago
Locationonline
ProgrammesProspective applicants for the European Innovation Council interested in the upcoming opportunities under the EIC Work Programme 2025 are warmly invited to join this online Info Day
High-level speakers from the European Innovation Council and SMEs Executive Agency (EISMEA) and the Directorate-General for Research and Innovation (DG RTD) of the European Commission and from the European Investment Bank (EIB) will provide an overview about three main funding schemes of by EIC:
Dedicated sessions will present the wide range of services (access to coaches, mentors, access to global partners & innovation ecosystem) offered to all EIC-funded projects and companies by the Business Acceleration Services (BAS) and the STEP call as a novelty under the Work Programme 2025.
More information and the link to the live-stream can be found here.
Registration is not requested.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health AI Continent Deployment: Best use of technologies
Security Digital, Industry & Space Cybersecurity
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
